Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients

NCT00472082 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped This study was terminated at the request of the drug manufacturer.

Conditions

Kidney Transplantation
Chronic Kidney Failure

Interventions

DRUG: efalizumab

Sponsor

Emory University

Collaborators

[object Object]